Benchmark Maintains Buy on Angi, Lowers Price Target to $14

Benzinga Newsdesk www.benzinga.com Negative 62.8%

Neg 62.8% Neu 0% Pos 0%

Benchmark analyst Daniel Kurnos maintains Angi (NASDAQ:ANGI) with a Buy and lowers the price target from $20 to $14.

Comments

No comments yet. Be the first!